Opinion|Videos|May 7, 2024

Evaluating the Impact of Metastatic Breast Cancer on Patients

An expert panel discusses the clinical and economic impact of metastatic breast cancer (mBC) on patients, the prognosis for those with mBC, the three FDA-approved CDK4/6 inhibitors for HR+/HER2- mBC, and the importance of overall survival as a clinical trial endpoint and its relevance to clinical practice.


Latest CME